Role of GLP 1 RA in Weight loss
- Mar 07, 2025
- 6:00PM TO 7:00 PM
- 00Days
- 00Hours
- 00Minutes
- 00Seconds
About the Case Presentation
GLP-1 receptor agonists (GLP-1 RAs) play a significant role in weight loss by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, which helps reduce appetite and food intake. These medications, originally developed for managing type 2 diabetes, have been shown to promote substantial weight loss in overweight and obese individuals, even in the absence of diabetes. GLP-1 RAs, such as liraglutide and semaglutide, have been approved for weight management and are often used alongside lifestyle interventions. Their effectiveness in weight loss, combined with improved metabolic control, makes them a promising treatment option for individuals struggling with obesity.
About the Speaker
Dr. Leena Mahana Kapoor
Specialist Internal Medicine and Diabetologist, Aster DM Healthcare, Dubai
Dr. Leena Kapoor is an experienced and highly skilled internal medicine specialist with over 20 years of practice in the healthcare sector. She currently serves as a Physician at Aster DM Healthcare in the United Arab Emirates, where she has been working since December 2022. Prior to this role, Dr. Kapoor held a long tenure as a Specialist in Internal Medicine at Prime Healthcare Group in Dubai from September 2012 to December 2022. She also served as the Head of the Department of Internal Medicine at Zulekha Hospital for over seven years, from May 2004 to January 2012. Dr. Kapoor’s educational background includes a Postgraduate Diploma in Endocrinology from the University of South Wales and completion of the Gulf Cardiometabolic Masterclass Course in Endocrinology, Diabetes, and Metabolism in 2021. With extensive experience across various medical institutions, Dr. Kapoor continues to make significant contributions to patient care and the field of internal medicine.